Viewing Study NCT05920668


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2026-01-10 @ 1:45 AM
Study NCT ID: NCT05920668
Status: UNKNOWN
Last Update Posted: 2023-06-27
First Post: 2023-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma
Sponsor: Wang Xin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module